Eriobotrya japonica (Loquat) Leaf Extract: An Integral In Vitro and In Ovo Approach to Antimelanoma Potential and Safety
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177676 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Andreea Maria Cristea und 10 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, …. Hauptthemen laut MEDLINE: Eriobotrya, Plant Extracts, Plant Leaves, Melanoma. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Melanoma continues to be one of the most challenging diseases in oncology, given its aggressiveness and increased resistance to existing therapies. Therefore, the identification of novel therapeutic strategies is of considerable interest, with medicinal plants representing a promising source of bioactive compounds. In the present study, the phytochemical profile and the in vitro biological activity of a lyophilized aqueous leaf extract of Eriobotrya japonica (Thunb.) Lindl. cultivated in Romania were investigated. The extract was characterized by determining the total phenolic content, antioxidant capacity, and polyphenolic composition using UHPLC-MS/MS. Its cytotoxic potential and cytocompatibility were evaluated at concentrations of 50, 100, 200, 300, 400, and 500 µg/mL in two human melanoma cell lines (RPMI 7951 and A375) and in the human keratinocyte cell line HaCaT. Cell viability and morphological alterations were assessed in all three cell lines. Subsequently, the study focused on assessing the effects of the extract on melanoma cells by evaluating lysosome integrity and the intracellular production of reactive oxygen species (ROS). The impact on mitochondrial membrane potential, as well as on mitochondrial and nuclear morphology, was also determined. Finally, the HET-CAM test was carried out to assess the extract’s preliminary irritant potential at 500 µg/mL. The results showed that the extract presented a high content of phenolic compounds and high antioxidant capacity. The most abundant compounds in the extract were chlorogenic acid, rutin, 3,5-dihydroxybenzoic acid/3,4-dihydroxybenzoic acid, and p-coumaric acid/trans-p-coumaric acid. With regard to biological activity, the treatment induced low cytotoxicity in HaCaT cells including at 500 µg/mL. At the same time, it produced a dose-dependent reduction in the viability of melanoma cells, accompanied by impaired lysosomal integrity. It was observed that the extract increased ROS levels and mitochondrial membrane depolarization, thereby inducing morphological changes at the mitochondrial and nuclear levels. However, across all performed assays, the most pronounced effects were observed starting at a concentration of 300 µg/mL. The HET-CAM assay classified the extract as non-irritant at 500 µg/mL. These findings suggest that Eriobotrya japonica leaf extract exerts antimelanoma effects associated with oxidative stress and mitochondrial dysfunction while maintaining a favorable preliminary safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Clinic of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania.
- Research Centre for Pharmaco-Toxicological Evaluation, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania.
- Doctoral School, "Victor Babes" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania.
- Biochemistry and Pharmacology Department, Discipline of Pharmacology, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timișoara, Romania.
- Department of Pharmaceutical Botany, Faculty of Pharmacy, "Victor Babes" University of Medicine and Pharmacy Timisoara, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania.
- Doctoral School "Engineering of Vegetable and Animal Resources", University of Life Sciences "King Mihai I", Aradului Street 119, 300645 Timisoara, Romania.
ORCID-Profile: Andreea Maria Cristea, Ioana Gabriela Macaşoi, Raluca Andreea Jupâneanț, Dorina Elena Coricovac, Diana-Simona Tchiakpe-Antal, Alex-Robert Jîjie, Alina Anton
Zitieren
APA
Cristea, A. M., Macaşoi, I. G., Haj Ali, D., Jupâneanț, R. A., Coricovac, D. E., Dehelean, C. A., Tchiakpe-Antal, D. S., Dumitrașcu, V., Jîjie, A. R., Lăcătuș, M., & Anton, A. (2026). Eriobotrya japonica (Loquat) Leaf Extract: An Integral In Vitro and In Ovo Approach to Antimelanoma Potential and Safety. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177676
Vancouver
Cristea AM, Macaşoi IG, Haj Ali D, Jupâneanț RA, Coricovac DE, Dehelean CA, et al. Eriobotrya japonica (Loquat) Leaf Extract: An Integral In Vitro and In Ovo Approach to Antimelanoma Potential and Safety. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177676
BibTeX
@article{Cristea2026,
author = {Cristea, Andreea Maria and Macaşoi, Ioana Gabriela and Haj Ali, Diana and Jupâneanț, Raluca Andreea and Coricovac, Dorina Elena and Dehelean, Cristina Adriana and Tchiakpe-Antal, Diana-Simona and Dumitrașcu, Victor and Jîjie, Alex-Robert and Lăcătuș, Mihaela and Anton, Alina},
title = {Eriobotrya japonica (Loquat) Leaf Extract: An Integral In Vitro and In Ovo Approach to Antimelanoma Potential and Safety},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177676}
}
EUVIMED